
    
      Patients with a history of Hypoparathyroidism will be randomized to receive study drug for 8
      weeks, which will be injected daily in either thigh. During that time they will be monitored
      for safety (specifically calcium levels in blood or urine). In addition, the patients' intake
      of Vitamin D and Calcium will be measured.
    
  